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The cutaneous surface of a normal adult individual
contains approximately 20 billion T cells, nearly twice
the number present in the entire circulation. Recent
studies have shown a role for these cells in both
normal immunity and in inflammatory skin diseases
such as psoriasis. Regulatory T cells protect against
autoimmune reactions to self antigens and assist in
the resolution of cutaneous inflammation. However,
they can also shield tumors from immune detection,
allow latent infections to persist and can dysfunction
under the conditions present in inflammatory skin
diseases. Th17 T cells protect organisms against
extracellular pathogens but also have a key role in
the pathogenesis of psoriasis. Evidence suggests that
effector memory T cells produced during immune
reactions survive and persist long term within the
skin, providing local and rapid protection against
pathogen reexposure. This review summarizes the
current understanding of how skin-resident T cells
contribute to normal and aberrant immunity in the
skin.
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INTRODUCTION
T and B lymphocytes rearrange the DNA encoding their
antigen receptors and therefore have the capacity to recognize
any antigen. These cells also serve as the repositories for
immunologic memory; lymphocytes generated during an
immune response can persist for decades, providing rapid
and specific responses to rechallenge. T and B cells thus
provide highly flexible and long-lasting immunity.
Naive T cells are found primarily within the blood and
lymph nodes. Expression of the homing addressins L-selectin
and CCR7 supports the migration of naive T cells into lymph
nodes where they encounter dendritic cells (DC) bearing
antigen derived from the peripheral tissues (Warnock et al.,
1998; Baekkevold et al., 2001). When naive T cells
encounter their cognate antigen, they differentiate and gain
effector functions including cytotoxicity and cytokine pro-
duction. During this differentiation process, T cells are
imprinted to express tissue-specific homing addressins that
affect their subsequent migration patterns. In mice, naive
transgenic T cells developed expression of the gut homing
addressins a4b7 and CCR9 when they first encountered
antigen in the gut draining lymph nodes, but expressed the
skin homing addressins cutaneous lymphocyte antigen (CLA)
and CCR4 if they encountered antigen first in the skin-
draining lymph nodes (Campbell et al., 1999; Campbell and
Butcher, 2002). Further studies showed that both DC and
lymph node stromal cells have the ability to imprint homing
receptor expression on T cells (Mora et al., 2003, 2005; Edele
et al., 2008). Effector T cells are thus programmed during
differentiation to migrate to the tissue from which their
cognate antigen was originally derived.
When confronted by an infectious pathogen, the immune
system does two important things: it responds and it
remembers. Two different types of T cells are generated
during an immune response (Sallusto et al., 1999). Effector
memory T cells (TEM) upregulate expression of tissue homing
addressins and develop effector functions. These cells
predominate in the blood in the early stages of an immune
response, migrate into peripheral tissues and effect clearance
of the pathogen (Mackay et al., 1990; Whitton and Zhang,
1995). Following the peak of the immune response, most of
these cells disappear from the blood and a second popula-
tion, central memory T cells (TCM) predominates (Razvi et al.,
1995). Like naive T cells, TCM express the lymph node
homing addressins L-selectin and CCR7 and generally lack
addressins for peripheral tissues. TCM have lower levels of
effector functions but can proliferate vigorously and develop
into effector T cells when rechallenged with antigen (Sallusto
et al., 2004).
Until fairly recently, it was believed that T cells
only entered tissues such as the skin under conditions
of active inflammation (Kupper and Fuhlbrigge, 2004).
This review will discuss recent findings that skin and other
tissues are stably colonized by long-lived populations
of memory T cells. These tissue resident T cells provide long
lasting, local and rapid responses to pathogen reexposure but
can also contribute to inflammatory and autoimmune skin
diseases.
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Skin-resident T cells: hiding in plain sight
It has been known for decades that T cells are present in non-
inflamed human skin and it has been proposed that these
cells may comprise a skin-specific immune system (Bos et al.,
1987). Comprehensive study of these T cells and an under-
standing of their true numbers has been difficult because
mechanical or enzymatic dissociation of the skin produces
very few cells. Despite this difficulty, studies using histologic
methods or skin dissociation have successfully showed that
495% of the T cells in normal skin are CD45RO memory
T cells, o5% are naive, most express CLA, 50% express
CCR8 and a subset express CCR7 and CCR10 (Bos et al.,
1989; Campbell et al., 2001; Homey et al., 2002; Schaerli
et al., 2004).
T cells are arguably the most migratory cells in the body.
T cells enter and travel through every human tissue with
the likely exception of cortical bone. Unlike neutrophils
and monocyte-derived macrophages, T cell migration into
the tissues is not a one-way trip. T cells can migrate
into peripheral tissues and then return to the circulation
via migration through the lymph nodes. A simple method
of isolating skin T cells that took advantage of their tendency
to migrate towards chemokines produced by dermal
fibroblasts extracted surprising numbers of T cells
from normal human skin (Clark et al., 2006b). This
observation led to the enumeration of T cells in skin and
it was found that normal human skin contains about 1 million
T cells per cm2 (Clark et al., 2006a). Extrapolation of
this finding suggested that the skin of a normal adult contains
approximately 20 billion T cells, nearly twice the number
present in the entire blood volume. These T cells coexpressed
high levels of the skin homing addressins CLA and CCR4,
had a diverse T-cell repertoire and were polarized to produce
a variety of different cytokines in response to T-cell
stimulation (Clark et al., 2006a). T cells (80%) in skin lacked
expression of CCR7/L-selectin, confirming their identity
as effector memory T cells. T cells that did express CCR7
and L-selectin also coexpressed the skin addressins CLA
and CCR4, suggesting that they were an intermediate
phenotype capable of accessing both the skin and secondary
lymphoid organs.
At the time of these studies, it was assumed that TEM
primarily remained in circulation until recruited into the
tissues at sites of inflammation. Classical skin homing TEM
(CLAþ , CCR7/L-selectin) cannot enter the lymph nodes and
as a result, should be found either in the blood or the skin.
Enumeration of CLAþ T cells in skin and blood showed that
490% of CLAþ skin homing T cells were present in skin
under resting, non-inflamed conditions and that less than
10% were in peripheral circulation (Clark et al., 2006a).
Thus, even in the absence of inflammatory stimuli, the vast
majority of skin homing TEM were resident in skin and well
placed to respond to local challenges.
Local T-cell responses in skin: lessons from psoriasis
In considering the treatment of inflammatory skin diseases,
we and others have often focused on inhibiting the migration
of T cells into skin. E-selectin is expressed by all postcapillary
venules in skin and is upregulated with inflammation (Chong
et al., 2004; Kupper and Fuhlbrigge, 2004). By binding to
CLA expressed by skin homing T cells, E-selectin supports
lymphocyte rolling, the first step of T-cell entry into the skin
(Berg et al., 1991; Kupper and Fuhlbrigge, 2004) . It therefore
came as a surprise to find that blockade of E-selectin, which
should block migration of T cells into skin, was ineffective in
the treatment of psoriasis, a T-cell-mediated inflammatory
skin disease (Bhushan et al., 2002).
This result was made more intelligible by an elegant series
of experiments in mice grafted with human psoriatic skin.
Boyman et al. (2004) found that normal appearing, non-
lesional skin from patients with psoriasis developed
full-blown psoriatic lesions when transplanted onto immuno-
deficient mice but skin taken from normal patients did not.
Development of the psoriatic lesion was dependent on the
activation and local proliferation of a population of auto-
reactive T cells transferred with the initial skin graft. These
T cells were themselves stimulated into action by the local
production of IFN-a by plasmacytoid DC, likely produced in
response to the trauma of transplantation (Nestle et al., 2005).
This series of experiments showed two important things
about skin-resident T cells. First, T cells present in normal
appearing skin were able to give rise to a full psoriatic lesion
in the absence of T-cell recruitment from blood. Thus, T cells
resident in even normal appearing skin can initiate full blown
immune responses and although migration of T cells into the
skin from the blood occurs in many inflammatory conditions,
it may not always be required. In light of these experiments,
the failure of E-selectin blockade to control psoriasis became
understandable. Autoreactive T cells capable of initiating
psoriasis reside within the normal appearing skin of patients
with psoriasis. Preventing the entry of additional T cells into
skin does not address the threat posed by the lymphocytes
already present.
The second lesson from these experiments is that auto-
reactive T cells in the skin behave very differently depending
on their local inflammatory environment. Autoreactive T cells
exist in normal appearing skin from psoriatic patients but
these cells remain quiescent despite living side by side with
APC expressing and capable of presenting autoantigens. Only
when skin APC are activated to produce IFN-a do these
autoreactive T cells proliferate, produce cytokines and
initiate an active psoriatic lesion. This finding highlights the
importance of understanding how T cells are activated by
innate immune cells within the skin and explains why TNF
antagonists (etanercept, infliximab, adalimumab) and integrin
antibodies that disrupt APC/T-cell crosstalk (efalizumab,
alefacept) are effective in psoriasis whereas E-selectin
blockade is not (Bhushan et al., 2002; Griffiths, 2004).
Additional studies in mice and humans have confirmed
that T cells can become activated, proliferate and carry out
effector functions locally within the skin. As is described
more fully below, HSV-specific T cells in mice and humans
remained localized around latently infected nerves and
prevented HSV reactivation (Zhu et al., 2007; Wakim et al.,
2008b). In patients immunized with BCG and challenged
with a PPD, effector T cells proliferated within the skin at the
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PPD site (Vukmanovic-Stejic et al., 2006). In summary, all
elements necessary for a memory T-cell response –T cells and
APC — are resident within human skin and their interaction
can give rise to full secondary immune responses within the
skin.
Regulatory T cells in the skin: the good, the bad and the
ineffective
The immune system is faced with the difficult problem
of mounting immune responses to dangerous pathogens
while maintaining tolerance to the body’s own tissues and to
harmless or commensal organisms. Regulatory T cells (Tregs)
are one of many mechanisms developed by the immune
system to enforce tolerance to harmless and self antigens.
Tregs are critical to the development and maintenance of self-
tolerance and function by suppressing the activation,
cytokine production, and proliferation of other T cells
(Sakaguchi, 2005). These cells are characterized by high
expression of the transcription factor FOXP3 and by their
ability to suppress T-cell responses in vitro.
We have found that between 5 and 10% of the T cells
resident in normal human skin are FOXP3þ Tregs and that
these cells proliferate under conditions similar to those found
in inflamed skin (Clark and Kupper, 2007; Clark et al., 2008).
This suggests that local proliferation of Tregs in the skin may
serve as a brake for cutaneous inflammation. Indeed, Tregs
were observed to locally proliferate within human skin during
DTH reactions and increased numbers of Tregs were found in
the skin lesions of contact dermatitis and resolving fixed drug
eruptions (Teraki and Shiohara, 2003; Vukmanovic-Stejic
et al., 2008).
Recent experiments in mice support the idea that Tregs
decrease inflammatory tone in the skin. Mice with mutations
in FOXP3 lack Tregs and develop widespread and lethal
autoimmunity, a condition that can be prevented by
the transfer of wild-type Tregs (Khattri et al., 2003). These
mice were reconstituted with Tregs that lacked 1,3-fucosyl-
transferase VII, an enzyme necessary for formation of
E-selectin ligands (Maly` et al., 1996). These Tregs functioned
normally but had a selective inability to migrate into the
skin. These reconstituted mice had decreased inflammation
in the liver and lungs, consistent with normal homing of
Tregs to these sites, but they had marked skin inflammation.
These mice were kept in germ-free facilities and not exposed
to pathogens or other inflammatory stimuli, suggesting
that the activity of Tregs is needed to control inflamma-
tion even in normal, non-challenged skin. These experi-
ments also showed that Tregs need to be present within the
skin to exert their anti-inflammatory effects, as opposed to
suppressing skin inflammation by acting in the skin draining
lymph nodes. This work suggests that Tregs have a role in
maintaining homeostasis in normal skin and that they
function by locally suppressing the activity of other T cells
resident in skin.
For each mechanism of immune tolerance, there are
cancers and pathogens that co-opt it to escape immune
detection. Tregs are expanded in patients with many types of
cancer and are also often recruited into the tumors
themselves (Baecher-Allan and Anderson, 2006). 50% of
the T cells present in human squamous cell carcinomas of the
skin are FOXP3þ Tregs and increased Tregs have also been
observed in basal cell carcinomas, primary melanoma and
melanoma metastases (Kaporis et al., 2007; Mourmouras
et al., 2007; Ahmadzadeh et al., 2008; Clark et al., 2008).
Topical therapy of human squamous cell carcinomas with
imiquimod, a topical immunomodulator and TLR7 agonist,
reduced the percentage and suppressive function of Tregs,
suggesting that it may be useful in reversing Treg-induced
tumor tolerance (Clark et al., 2008). Tregs also enable latent
infection and induce reactivation of cutaneous leishmaniasis
and paracoccidiomycosis in mice and likely have a similar
role in humans (Belkaid et al., 2002; Xu et al., 2003).
Tregs have the capacity to be potently anti-inflammatory
but they are ineffective under certain conditions. Tregs can
suppress the activity of T cells which have received a low to
mid strength T-cell receptor (TCR) signal but cannot suppress
T cells that receive a high avidity TCR signal, such as those
observed in memory responses to dangerous pathogens
(Baecher-Allan et al., 2002). Tregs, therefore, act as the
immunologic equivalent of a high band pass filter, suppres-
sing T-cell responses with TCR avidities below a certain
threshold and allowing those with higher avidity signals to
proceed. Local production of the cytokine IL-6 also renders
T cells resistant to the suppressive effects of Tregs in mice and
preliminary work suggests this is also true in humans
(Goodman et al., 2007; Korn et al., 2007). Expression of the
chemokine receptor CCR5 is important for Treg migration
and suppressive ability; Tregs that lack CCR5 are less
effective in mouse models of paracoccidioidomycosis,
leishmaniasis and graft versus host disease (Wysocki et al.,
2005; Yurchenko et al., 2006; Moreira et al., 2008). Lastly,
Tregs can be outnumbered. In a mouse model of sarcoma, it
was the percentage of Tregs that determined if a tumor would
be tolerated or destroyed by the immune system (Bui et al.,
2006).
Considerable numbers of Tregs are present in the skin
lesions of psoriasis but these cells have decreased suppressive
activity (Sugiyama et al., 2005). IL-6 is increased in psoriatic
skin and this cytokine may interfere with the ability of Tregs
to suppress inflammation (Grossman et al., 1989; Goodman
et al., 2007) In addition, patients with psoriasis have fewer
CCR5þ Tregs than normal individuals and the CCR5þ Tregs
that are present in psoriatic patients have decreased function
(Sugiyama et al., 2008). Thus it appears that the Tregs present
within psoriatic lesions fail to suppress inflammation because
they are less active intrinsically and because their activity is
antagonized by the pro-inflammatory cytokine milieu in
psoriasis.
Th17 cells in the skin: key players in psoriasis
Th17 cells are a separate lineage of T cells that produce
the Th17 cytokines IL-17A, IL-17F, TNF-a, IL-21 and IL-22
and depend upon IL-23 for their development, survival and
proliferation (Harrington et al., 2005; Park et al., 2005). Th17
cells provide immunity against a variety of extracellular
pathogens, including bacteria such as Klebsiella pneumoniae
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and fungi such as Cryptococcus neoformans and Candida
albicans (Huang et al., 2004; Happel et al., 2005; Kleinschek
et al., 2006).
Th17 cells have also been implicated in a variety of
inflammatory and autoimmune disorders. IL-17 is increased
and Th17 cells are demonstrable in the synovial fluid and
tissues of patients with rheumatoid arthritis (Aarvak et al.,
1999; Chabaud et al., 1999; Kotake et al., 1999) and in the
brain lesions and CSF of patients with multiple sclerosis
(Matusevicius et al., 1999; Lock et al., 2002). Polymorphisms
in the IL-23R, a receptor required for the development and
survival of Th17 cells, are associated with susceptibility to
ulcerative colitis and Crohn’s disease (Duerr et al., 2006).
Th17 cells also contribute to the pathology observed in
mouse models of colitis, experimental autoimmune ence-
phalomyelitis and arthritis (Ouyang et al., 2008).
Increasing evidence suggests that Th17 cells are also key
players in the pathogenesis of psoriasis. DC and keratinocytes
in the skin lesions of psoriasis produce increased amounts of
IL-23, a cytokine that supports the development and
proliferation of Th17 cells (Lee et al., 2004; Piskin et al.,
2006; Wilson et al., 2007; Kryczek et al., 2008; Zaba et al.,
2008). Treatment of patients with monoclonal antibodies
against IL-12/23p40, a component shared between IL-12
and IL-23, led to significant clinical improvements in
psoriasis (Krueger et al., 2007; Kimball et al., 2008). Although
this finding could not discriminate between causative
roles for IL-23 versus IL-12, a role for IL-23 in psoriasis is
supported by genetic studies showing that polymorphisms in
the IL-23 receptor and other genes in the IL-23-signaling
pathway are associated with psoriasis (Capon et al., 2007;
Cargill et al., 2007; Nair et al., 2008, 2009). Th17 cells
are demonstrable in psoriatic lesions and are found in
higher numbers than in normal human skin (Kryczek et al.,
2008; Lowes et al., 2008). Th17 cells produce the cytokine
IL-22, a cytokine that induces human keratinocyte prolifera-
tion and acanthosis in vitro (Sa et al., 2007). Injection of
IL-23 into the skin of mice induced dermal inflammation
and epidermal acanthosis reminiscent of the changes seen
in psoriasis and these effects were found to be mediated
through production of IL-22 (Chan et al., 2006; Zheng et al.,
2007). These findings support a role for IL-23 in supporting
the survival, proliferation and function of Th17 T cells that
in turn contribute to psoriasis through their production of
IL-22 and other inflammatory cytokines. These observa-
tions suggest that selective disruption of IL-23 signaling
(for example, by targeting IL-23p19 subunit) should lead
to reduced Th17 T cells and potentially to long-lasting
improvements in psoriasis.
Tissue resident T cells: on site immune memory
Central memory T cells (TCM) persist long term in the
circulation following resolution of an immune response, a
finding that led researchers to propose that TCM are the only
T cells responsible for maintaining long-term immunologic
memory (Lanzavecchia and Sallusto, 2005). This contention
is at odds with clear and elegant experiments in mice
showing that TEM do persist long term — not in the blood but
within the peripheral tissues (Masopust et al., 2001;
Reinhardt et al., 2001). In animal models, T cells generated
during immune responses in the skin, gut, and lungs persist
within these tissues and provide protection against reinfection
at these sites (Liang et al., 1994; Hogan et al., 2001b; Xu
et al., 2004; Stittelaar et al., 2005). A series of elegant studies
examining HSV infection of the skin in mice have provided
some intriguing details about the nature of these cells.
Following infection with HSV, CD8 antigen-specific T cells
accumulated near latently infected dorsal root ganglia and
suppressed reactivation of the virus (van Lint et al., 2005;
Wakim et al., 2008b). Reinfection with HSV led to local
proliferation of these resident cells and also recruitment of
additional antigen-specific T cells from the circulation
(Wakim et al., 2008a). There were therefore two populations
of antigen-specific T cells capable of responding to rechal-
lenge: skin-resident T cells that arose and were on site as a
result of the primary infection and circulating antigen-specific
T cells that were newly recruited from the blood. Using GFP-
expressing mice and serial transplantation of latently infected
ganglia, this group dissected the contributions and character-
istics of these two cell types (Gebhardt et al., 2009).
Surprisingly, antigen-specific tissue resident T cells generated
during the primary immune response remained in the same
location over 100 days after primary HSV infection. These T
cells failed to re-enter the circulation and did not even
migrate into infected ganglia transplanted in direct approx-
imation. Antigen-specific T cells were present in highest
numbers at the site of initial infection but were also
demonstrable in other locations within the skin. These tissue
resident T cells provided enhanced local protection against
reinfection with HSV. Skin-resident T cells that accumulated
after HSV infection lacked L-selectin and expressed higher
levels of the activation antigen CD69 than T cells recruited
from blood, a finding that has been replicated in humans
(Clark et al., 2006a). These studies showed that a functionally
distinct, non-migratory population of skin-resident T cells
arose following viral infection, persisted long-term within the
skin and provided effective protection against local reinfec-
tion. In humans, a similar population of HSV-specific T cells
was found resident in the skin of military recruits more than
2 months after clearance of a primary HSV infection and these
T cells increased in number during subclinical HSV reactiva-
tion (Zhu et al., 2007). Antigen-specific T cells also persisted
long term locally in the skin at the site of PPD injection in
BCG-vaccinated individuals (Vukmanovic-Stejic et al., 2006).
The finding that skin-resident T cells are a sessile, non-
migratory population may help to explain some of the
puzzling eruptions we see in dermatology. Fixed drug
eruptions are local skin lesions that occur following ingestion
of a causative drug, spontaneously resolve once the drug is
discontinued, then recur in the same location years or even
decades later when the drug is taken again. Histologically,
this eruption is a cytotoxic reaction against epidermal
keratinocytes mediated by a CD8 T cells and indeed, a
population of CD8 T cells producing IFN-g and TNF-a is
found within the epidermis of clinically resolved, hyperpig-
mented fixed drug eruptions lesions (Teraki et al., 1994;
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Shiohara and Moriya, 1997; Teraki and Shiohara, 2003). The
fixed location of this eruption may reflect the fixed location of
a population of drug reactive T cells resident in skin.
Similarly, it is striking how psoriatic plaques remain in the
same location long-term and tend to recur in the same
locations following cessation of suppressive therapy. Given
the evidence that autoreactive Th17 cells may drive this
disease, it is tempting to speculate that each psoriatic plaque
represents a population of autoreactive skin-resident Th17
cells. However, changes in other cell types could also
mediate this localized behavior, including fixed populations
of pathogenic APC or possibly fixed changes in the blood
vessels at these sites. Lastly, the different behavior of central
memory and skin-resident effector memory T cells may
underlie the differing clinical manifestations we observe in
cutaneous T-cell lymphoma. In patients with stage IA mycosis
fungoides, malignant T cells are confined to stable patches
and plaques on the skin and life expectancy is normal (Kim
et al., 2003). In Se´zary syndrome, the malignant T cells
migrate throughout the entire skin surface, giving rise to
erythroderma, and also colonize the blood and lymph nodes.
Intriguing new data suggest that the malignant T cells in
mycosis fungoides are skin-resident effector memory cells, a
population expected to remain in a fixed position. However,
malignant T cells in Se´zary syndrome bear markers suggestive
of central memory T cells, a cell type that normally migrates
through the blood, lymph nodes, and can also be found in
low numbers in normal human skin (Clark et al., 2006a;
Campbell et al., 2009). The fact that malignant central
memory T cells give rise to diffuse erythroderma and
malignant skin-resident T cells give rise to fixed plaques of
inflamed skin is an eloquent argument in favor of the mobile
versus sessile nature of these two lymphocyte subsets.
Other tissues have their own populations of resident
T cells that contribute local immune protection. In mice,
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Figure 1. Contributions of TEM and TCM to primary immune responses in the skin. After pathogen exposure, DC take up antigen, migrate to the skin draining
lymph nodes and present it to naı¨ve T cells. Naı¨ve T cells that recognize their cognate antigen undergo differentiation and polarization into skin homing
effector memory T cells (TEM) and central memory T cells (TCM). TEM leave the lymph nodes, enter the circulation and migrate into the skin where they effect
clearance of the pathogen. TEM colonize all areas of the skin but are found in highest numbers at sites of pathogen exposure. In the early stages of the immune
response, proliferating T cells are also released from the skin draining lymph nodes and migrate to antigen-free lymph nodes draining other peripheral tissues.
T cells continue to proliferate within these lymph nodes, giving rise to new populations of TEM that home to gut, lungs and other peripheral tissues.
In this way, immunization through the skin gives rise to a diverse population of tissue resident T cells that provide systemic immune protection.
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the lung several months after recovery from influenza or
Sendai virus infection (Hogan et al., 2001a). It was the
number of lung resident pathogen-specific T cells and not the
number in the lymph nodes that correlated with protection
against reinfection. The gut epithelium in mice is colonized
by CD8 memory T cells with substantial lytic activity
(Masopust et al., 2001). Murine intraepithelial CD8 cells
bearing the ab TCR and both ab CD8 chains (comparable to
conventional T cells) are scarce in the gut at birth but
progressively increase throughout life as antigen-experienced
T cells accumulate (Cheroutre, 2004; Cheroutre and
Madakamutil, 2004). Gut resident T cells isolated from mice
that have recovered from pathogens, such as Toxoplasma
gondii protect against infection when transferred into naive
animals (Lepage et al., 1998).
Central and tissue resident T cells: an integrated view
To conceptualize how TEM and TCM contribute to immunity,
it may be helpful to describe their contributions to both
naive and memory T-cell responses in the skin. During a
primary immune response, when the immune system
encounters an antigen for the first time, the antigen is taken
up by skin-resident DC and these cells migrate to the
skin-draining lymph nodes (Figure 1). Within the lymph
nodes, DC present antigen to naive T cells. Upon recogni-
tion of cognate antigen, naive T cells undergo differentia-
tion and polarization into skin homing TEM and TCM. TEM
then migrate through the bloodstream and are distributed
to all parts of the skin, although the highest numbers of
these cells will be found at the site of pathogen exposure
(Gebhardt et al., 2009). These cells effect clearance of
the pathogen and then remain resident locally within the
skin (Gebhardt et al., 2009). In the early stages of a primary
immune response, proliferating T cells are also released
from the skin-draining lymph nodes and distribute to antigen-
free lymph nodes draining other tissues (Liu et al., 2006).
T cells continue to proliferate within these new lymph nodes
and give rise to new populations of effector T cells that
migrate to and take up residence in the gut, lungs and
other peripheral tissues. In this way, immunization through
the skin actually generates widespread systemic immunity
via the generation of disparate populations of tissue resident
TEM cells.
In a memory immune response, T-cell responses can be
divided into three distinct stages (Figure 2). First, local re-
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Figure 2. The role of TEM and TCM in recall immune responses. Memory immune responses can be divided into three stages. First, DC take up antigen following
pathogen re-exposure and present it to TEM resident locally within the skin. These cells proliferate and effect clearance of the pathogen. Second, inflammation
leads to endothelial activation and nonspecific recruitment of T cells from the blood. The small numbers of antigen-specific T cells recruited into the skin
in this way can also participate in clearance of the pathogen. Third, DC carry endocytosed antigen to the skin draining lymph nodes where it is presented to
TCM. These TCM then give rise to new populations of skin homing TEM that migrate to the skin and clear the infection.
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antigen presentation by tissue-resident DC. These DC
stimulate the proliferation and effector functions of antigen-
specific skin-resident T cells located in the skin, leading to
rapid neutralization of the pathogen (Wakim et al., 2008b).
Second, local inflammation leads to upregulation of vascular
adhesion receptors on the skin endothelium, leading to
nonspecific recruitment of T cells from the circulation. Only a
minority of these T cells will be antigen specific, yet the small
numbers of antigen-specific cells that do enter the skin under
these conditions have been shown to contribute to immune
responses (Wakim et al., 2008a). Third, migration of antigen
laden DC to the skin draining lymph nodes will lead to
stimulation of TCM and the subsequent production of large
numbers of skin-homing TEM. These TEM will then migrate
through the bloodstream, enter areas of inflamed skin, and
affect clearance of the pathogen.
T cells have the flexibility to respond to any antigen,
to migrate to any tissue, and to produce a plethora
of cytokines and effector functions fine tuned to efficiently
eliminate pathogens and tumors. Although tissue-resident
T cells have been described in gut, lung and skin, it is likely
that all tissue types have to some degree their own
populations of resident T cells. By populating both the
peripheral tissues and the lymph nodes with distinct types of
memory T cells, the adaptive immune system manages to
provide both flexibility and the ability to neutralize pathogens
rapidly.
Human skin is populated by 20 billion T cells, charged
with the responsibility of locally defending the skin against
tumors and pathogens when maintaining tolerance to self
antigens exposed during injury. The evolution of this system
of local T-cell deposition, combined with amount of energy
it takes to generate and maintain these cells, make it clear
that defending the skin is a high priority for the immune
system. However, skin-resident T cells can dysfunction; these
cells can fail to suppress pathogenic inflammation, shield
tumors and infections with T cells designed to limit
autoimmunity and generate autoreactive T cells that can
initiate psoriasis and other inflammatory skin diseases.
Studies of the antigen specificity of skin-resident T cells and
how they are activated in skin are likely to identify ways that
T-cell function can be enhanced in tumors and inhibited in
inflammatory skin disorders. Because immune reactions in
skin can be visually observed, sampled and manipulated with
topical medications, the skin provides an accessible site in
which to study human immune responses. Novel therapies
arising from an understanding of T biology in skin should be
broadly applicable to pathogenic immune states in other
tissues.
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